PASSAGE BIO INC's ticker is PASG and the CUSIP is 702712100. A total of 103 filers reported holding PASSAGE BIO INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $9,701 | -50.1% | 10,129 | -28.1% | 0.00% | – |
Q4 2022 | $19,437 | -60.3% | 14,085 | -64.1% | 0.00% | – |
Q3 2022 | $49,000 | -64.0% | 39,210 | -32.0% | 0.00% | -100.0% |
Q2 2022 | $136,000 | -30.6% | 57,620 | -8.7% | 0.00% | -50.0% |
Q1 2022 | $196,000 | -37.2% | 63,107 | +28.4% | 0.00% | -33.3% |
Q4 2021 | $312,000 | +27.9% | 49,130 | +100.5% | 0.00% | 0.0% |
Q3 2021 | $244,000 | -57.5% | 24,508 | -43.5% | 0.00% | -50.0% |
Q2 2021 | $574,000 | +205.3% | 43,348 | +302.9% | 0.01% | +200.0% |
Q1 2021 | $188,000 | – | 10,759 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Leaf Venture Partners, L.L.C. | 2,497,922 | $63,872,000 | 14.76% |
FRAZIER MANAGEMENT LLC | 5,009,219 | $128,086,000 | 9.86% |
HIGHLINE CAPITAL MANAGEMENT, L.P. | 602,248 | $15,399,000 | 7.53% |
Vivo Capital, LLC | 1,487,038 | $38,024,000 | 1.70% |
Boxer Capital, LLC | 1,928,315 | $49,307,000 | 1.58% |
Orbimed Advisors | 6,962,899 | $178,041,000 | 1.56% |
Logos Global Management LP | 344,438 | $8,807,000 | 0.76% |
EMERALD ADVISERS, LLC | 340,698 | $8,712,000 | 0.29% |
Ikarian Capital, LLC | 136,697 | $3,495,000 | 0.15% |
Weiss Multi-Strategy Advisers LLC | 300,554 | $7,685,000 | 0.15% |